Literature DB >> 535394

Biotypic and serotypic profiles of 367 Yersinia enterocolitica cultures of human and environmental origin in the United States.

T J Quan.   

Abstract

Between 1972 and March 1977, 367 cultures of Yersinia enterocolitica were examined for biotypic and serotypic characteristics by Plague Branch, Vector-Borne Diseases Division, Center for Disease Control. Standard biotyping tests were performed. Serotyping antisera used contained somatic serofactors 1 through 9, 11 through 21, 24, 32, and two new types designated 'Arizona' and 'Tacoma'. The cultures examined included 68 from human illnesses; 43 from 12 species of vertebrate and invertebrate animals; 43 from raw meats, milk, or seafood; and 215 from 154 different water samples. Geographic origins of the cultures included 16 states of the USA and four provinces of Canada.

Entities:  

Mesh:

Year:  1979        PMID: 535394

Source DB:  PubMed          Journal:  Contrib Microbiol Immunol        ISSN: 0301-3081


  5 in total

1.  Antigenic identity of Yersinia enterocolitica serotypes O:Tacoma and O21.

Authors:  D A Schiemann
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

2.  Infection caused by Yersinia enterocolitica serotype O:21.

Authors:  M A Karmali; S Toma; D A Schiemann; S H Ein
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

3.  Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States.

Authors:  B A Kay; K Wachsmuth; P Gemski; J C Feeley; T J Quan; D J Brenner
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

4.  Epidemiologic investigation of a Yersinia camp outbreak linked to a food handler.

Authors:  D L Morse; M Shayegani; R J Gallo
Journal:  Am J Public Health       Date:  1984-06       Impact factor: 9.308

5.  Proposed revision of the Wauters et al. antigenic scheme for serotyping of Yersinia enterocolitica.

Authors:  S Aleksić; J Bockemühl
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.